Ligand Pharmaceuticals ($LGND) Insider Trading & Smart Money Activity
Ligand Pharmaceuticals Incorporated ($LGND) has 6 insider trades, 1 congress trade and 1 13F position change on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($3.19M), net -$3.19M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$3.19M
- Congress trades (12 mo)
- 1
- 13F moves on file
- 1
- Analyst ratings on file
- 0
LGND insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $1.67M | 1 / 0 | 0 / 1 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $1.52M | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All LGND insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Reardon AndrewCLO & Secretary | Sell (Open-market sale) 10b5-1 | 5K sh | $1.52M | -0.4% | — | |||||
| Insider | Stephen Sabba | Sell (Open-market sale) | 2.15K sh | $544.83K | +9.5% | +16.1% | Read | ||||
| Insider | Stephen Sabba | Buy (Option exercise) | 2.15K sh | $141.85K | +9.5% | +16.1% | Read | ||||
| Insider | Jason Haas | Sell (Option exercise) | 4K sh | +2.6% | +21.0% | Read | |||||
| Insider | Jason Haas | Buy (Option exercise) | 4K sh | $206.24K | +2.6% | +21.0% | Read | ||||
| Insider | Jason Aryeh | Sell (Open-market sale) | 4.50K sh | $1.12M | +8.0% | +21.5% | — | ||||
| Congress | Gilbert Cisneros | Purchase | $1,001 - $15,000 | +2.2% | +35.4% | Read | |||||
| 13F | Loomis Sayles & Co L P | Reduced | -29.47K sh | $111.13M | +1.5% | +15.6% | — |
1W / 1M / 6M = how LGND moved from the trade or filing date.
Insider trading in LGND: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Reardon Andrew | CLO & Secretary | 1 | -$1.52M | Oct 2, 2026 | |
| Stephen Sabba | 2 | -$544.83K | Jun 16, 2026 | ||
| Jason Haas | 2 | — | Jun 12, 2026 | ||
| Jason Aryeh | 1 | -$1.12M | Jun 11, 2026 |
Members of Congress trading LGND
Institutions moving LGND (13F)
Frequently asked questions
Are LGND insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 3 open-market sales worth $3.19M, a net -$3.19M.
What is the latest insider trade in LGND?
Reardon Andrew, CLO & Secretary filed a sell (open-market sale) of 5K sh worth $1.52M on Oct 2, 2026.
Which members of Congress traded LGND?
1 disclosed trade by Gilbert Cisneros. The latest was on May 29, 2026.
Which institutions changed their LGND positions?
Recent 13F filers moving the stock include Loomis Sayles & Co L P.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.